TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Shionogi & Co ( (JP:4507) ).
Shionogi & Co., Ltd. has announced new management policies aimed at enhancing their awareness of capital costs and stock prices, following a Board of Directors meeting. This strategic move is expected to influence the company’s operational focus and potentially impact its market positioning and stakeholder interests.
The most recent analyst rating on (JP:4507) stock is a Buy with a Yen2770.00 price target. To see the full list of analyst forecasts on Shionogi & Co stock, see the JP:4507 Stock Forecast page.
More about Shionogi & Co
Shionogi & Co., Ltd. is a pharmaceutical company based in Osaka, Japan, known for its focus on developing and marketing pharmaceutical products. The company is engaged in research and development, manufacturing, and distribution of medications, with a strong emphasis on addressing healthcare needs through innovative solutions.
YTD Price Performance: 13.08%
Average Trading Volume: 2,301,334
Technical Sentiment Signal: Buy
Current Market Cap: Yen2148.7B
For an in-depth examination of 4507 stock, go to TipRanks’ Overview page.